Coronary artery disease risk prediction by combined stratification of low‐density lipoprotein‐cholesterol and high‐density lipoprotein‐cholesterol levels across different glucose statuses

Junko Yachida,Kazuya Fujihara,Mayuko Harada Yamada,Ayako Kobayashi,Lay Mon Khin,Hiroki Takizawa,Masahiko Yamamoto,Masaru Kitazawa,Yasuhiro Matsubayashi,Takaho Yamada,Satoru Kodama,Hirohito Sone

DOI: https://doi.org/10.1111/dom.15956

2024-09-26

Diabetes Obesity and Metabolism

Abstract:Aim To investigate the association between low‐density lipoprotein‐cholesterol (LDL‐C) levels and coronary artery disease (CAD) incidence based on combining high‐density lipoprotein‐cholesterol (HDL‐C) levels and glucose status. Materials and Methods In this retrospective cohort study, we used data from a nationwide claims database (1,524,289 individuals without a history of CAD or familial hypercholesterolaemia; 2008–2019). Cox proportional hazards modelling identified the risk of incident CAD by a novel combination of four HDL‐C levels, seven LDL‐C levels and glucose status. Results During the follow‐up period (mean: 5.5 years), 8301 (0.99/1000 person‐years) events occurred. The risk of CAD increased from lower LDL‐C levels accompanied by lower HDL‐C levels regardless of the glucose status. Using the most favourable levels of HDL‐C and LDL‐C (i.e. 60–99 mg/dL and <80 mg/dL, respectively) as references, the hazard ratios (95% confidence interval) for the group with HDL‐C levels <40 mg/dL and LDL‐C levels <80 mg/dL were 2.74 (1.47–5.11), 2.52 (1.30–4.91) and 2.85 (1.68–4.84) for normoglycaemia, borderline glycaemia and diabetes, respectively. Comparison of the most favourable levels of HDL‐C and LDL‐C with their least favourable levels (i.e. <40 mg/dL and 180–199 mg/dL, respectively) revealed that the risk of new‐onset CAD exhibited a 19‐, nine‐ and seven‐fold increase in individuals with normoglycaemia, borderline glycaemia and diabetes, respectively. Conclusions To prevent CAD, LDL‐C levels should be strictly controlled in patients with low HDL‐C levels regardless of glucose tolerance. Individualized treatment, which involves setting target LDL‐C levels based on glucose tolerance and HDL‐C values, is required.

endocrinology & metabolism